Molecular Characterization of NS5A Resistance Associated Substitutions after Failure of Sofosbuvir/Daclatasvir Combination Therapy in Chronic Hepatitis C genotype 4a Infected Egyptian Patients Compared to Direct-acting Antiviral Agent (DAA)-naïve Sequences